ExploreWatchlistsPricing
  1. JP-listed companies
  3. Ownership

(219A) Shareholders

Market cap
¥41.1B
P/E ratio
-18.8x
Heartseed develops regenerative heart muscle therapies using iPS cell-derived cardiac spheres to treat severe heart failure patients through medical institutions worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce

大株主

（単位：千株）2024/102025/12
福田 惠一3,200
14.4%		3,146
13.76%
SBI Ventures Two2,236.8
10.06%		2,236.8
9.79%
古川 俊治1,120
5.04%		920
4.02%
新村 健造594.2
2.67%		842.4
3.69%
イノベーション企画21650
2.84%
JMDC461.6
2.08%		461.6
2.02%
秋山 琢己1,120
5.04%		441
1.93%
五味 大輔350
1.53%
SBI AI&Blockchain投資事業有限責任組合1,539.2
6.93%		264.7
1.16%
メディパルホールディングス250
1.09%
河西 佑太郎800
3.6%
Astellas Venture Management LLC．708.8
3.19%
日本カストディ銀行616.3
2.77%
計12,396.9
55.78%		9,562.5
41.83%
AI Chat